VIENNA, Austria—For patients with persistent atrial fibrillation (AF), a hybrid approach that combines a minimally invasive surgical ablation with catheter-based radiofrequency ablation—performed ...

Pulse Biosciences (Nasdaq:PLSE) announced a new strategic alignment to focus on its nPulse cardiac catheter ablation system.

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the successful ...

Please provide your email address to receive an email when new articles are posted on . “The current practice of radiofrequency ablation with power-controlled irrigated catheters involves the delivery ...

Please provide your email address to receive an email when new articles are posted on . The debate on the use of catheter ablation in patients with atrial fibrillation has intensified among ...

Advanced Cardiac Therapeutics raised $45 million in equity, which will drive a global clinical development program for its next-generation ablation catheter for the treatment of atrial fibrillation ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), pioneer of the novel nPulse™ platform using proprietary Nanosecond Pulsed Field Ablation (nsPFA™), today announced a new strategic alignment to prioritize and ...

Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...

Catheter ablation was favored for rhythm control in atrial fibrillation (Afib or AF) when considering its psychological benefits over medical therapy alone, the REMEDIAL randomized trial showed.

Patients with structural heart disease are at risk for life-threatening ventricular tachycardias (VTs). Implantable cardioverter-defibrillators (ICDs) can terminate VT, but often at the cost of ...

Among patients with atrial fibrillation, those with a recent stroke are at significantly higher risk of recurrence than those without. Catheter ablation is expected to reduce the risk of ...

MINNEAPOLIS--(BUSINESS WIRE)--Imricor Medical Systems, Inc. (ASX:IMR) today announces that it has received CE mark approval for its Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode. This ...